Variant report

Variant	nsv465464
Chromosome Location	chr8:10537940-10565263
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:348)
CpG islands
(count:244)
Chromatin interactive
region (count:21)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:348 , 50 per page) page: 1 2 3 4 5 6 7

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr8:10547285-10547485	K562	blood:	n/a	n/a
2	ATF1	chr8:10556072-10556385	K562	blood:	n/a	n/a
3	ATF3	chr8:10538386-10538728	A549	lung:	n/a	n/a
4	ATF3	chr8:10556054-10556401	K562	blood:	n/a	n/a
5	BCL3	chr8:10538308-10538830	A549	lung:	n/a	n/a
6	BCL3	chr8:10538290-10538870	A549	lung:	n/a	n/a
7	BHLHE40	chr8:10547066-10547446	K562	blood:	n/a	n/a
8	BHLHE40	chr8:10548293-10549087	K562	blood:	n/a	chr8:10548805-10548821 chr8:10548940-10548956
9	BHLHE40	chr8:10556120-10556373	K562	blood:	n/a	n/a
10	BRCA1	chr8:10538366-10538794	Hela-S3	cervix:	n/a	n/a
11	BRCA1	chr8:10548322-10549104	Hela-S3	cervix:	n/a	n/a
12	CBX3	chr8:10548378-10548714	K562	blood:	n/a	n/a
13	CBX3	chr8:10560231-10560479	K562	blood:	n/a	n/a
14	CEBPB	chr8:10556053-10556413	K562	blood:	n/a	chr8:10556221-10556232
15	CEBPB	chr8:10544799-10544897	HepG2	liver:	n/a	chr8:10544848-10544859
16	CEBPB	chr8:10556051-10556400	IMR90	lung:	n/a	chr8:10556221-10556232
17	CEBPB	chr8:10538372-10538912	Hela-S3	cervix:	n/a	n/a
18	CEBPB	chr8:10556072-10556406	Hela-S3	cervix:	n/a	chr8:10556221-10556232
19	CEBPB	chr8:10548379-10549212	Hela-S3	cervix:	n/a	n/a
20	CEBPB	chr8:10556056-10556388	HepG2	liver:	n/a	chr8:10556221-10556232
21	CEBPB	chr8:10563317-10563560	HepG2	liver:	n/a	n/a
22	CEBPB	chr8:10538263-10538912	A549	lung:	n/a	n/a
23	CEBPB	chr8:10563484-10563575	K562	blood:	n/a	n/a
24	CEBPB	chr8:10557100-10557263	K562	blood:	n/a	n/a
25	CEBPB	chr8:10556061-10556406	A549	lung:	n/a	chr8:10556221-10556232
26	CEBPB	chr8:10556073-10556387	K562	blood:	n/a	chr8:10556221-10556232
27	CEBPB	chr8:10563398-10563608	IMR90	lung:	n/a	n/a
28	CEBPB	chr8:10556133-10556276	K562	blood:	n/a	chr8:10556221-10556232
29	CHD1	chr8:10547388-10547392	GM12878	blood:	n/a	n/a
30	CHD2	chr8:10538401-10538873	Hela-S3	cervix:	n/a	n/a
31	CHD2	chr8:10548267-10549252	Hela-S3	cervix:	n/a	n/a
32	CREB1	chr8:10538427-10538870	A549	lung:	n/a	n/a
33	CTCF	chr8:10539350-10539429	MCF-7	breast:	n/a	n/a
34	CTCF	chr8:10539300-10539450	Hela-S3	cervix:	n/a	n/a
35	CTCF	chr8:10540020-10540170	GM12868	blood:	n/a	n/a
36	CTCF	chr8:10539340-10539490	HUVEC	blood vessel:	n/a	chr8:10539477-10539490
37	CTCF	chr8:10539340-10539490	GM12873	blood:	n/a	chr8:10539477-10539490
38	CTCF	chr8:10539460-10539610	NHEK	skin:	n/a	chr8:10539477-10539490
39	CTCF	chr8:10548480-10548630	HRPEpiC	eye:	n/a	n/a
40	CTCF	chr8:10539361-10539426	Hela-S3	cervix:	n/a	n/a
41	CTCF	chr8:10538680-10538830	HUVEC	blood vessel:	n/a	n/a
42	CTCF	chr8:10556697-10556747	NHEK	skin:	n/a	n/a
43	CTCF	chr8:10539300-10539450	HepG2	liver:	n/a	n/a
44	CTCF	chr8:10554124-10554214	GM20000	blood:	n/a	n/a
45	CTCF	chr8:10539428-10539437	Hela-S3	cervix:	n/a	n/a
46	CTCF	chr8:10546560-10546710	HFF-Myc	foreskin:	n/a	n/a
47	CTCF	chr8:10552860-10553010	NHEK	skin:	n/a	chr8:10552951-10552969 chr8:10552957-10552966
48	CTCF	chr8:10539220-10539370	HMEC	breast:	n/a	n/a
49	CTCF	chr8:10538722-10538796	Hela-S3	cervix:	n/a	n/a
50	E2F4	chr8:10556184-10556402	MCF10A-Er-Src	breast:	n/a	n/a

(count:244 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr8:10553728-10553778	T-47D	breast:	n/a
2	chr8:10555466-10555516	AG09319	gingival:	n/a
3	chr8:10553728-10553778	SKMC	muscle:	n/a
4	chr8:10558000-10558050	NH-A	brain:	n/a
5	chr8:10555382-10555432	A549	lung:	n/a
6	chr8:10555382-10555432	AG04449	skin:	fetal
7	chr8:10555466-10555516	Jurkat	blood:	n/a
8	chr8:10555382-10555432	HEK293	kidney:	embryo
9	chr8:10555466-10555516	HNPCEpiC	eye:	n/a
10	chr8:10558000-10558050	GM19239	blood:	n/a
11	chr8:10558000-10558050	PrEC	prostate:	n/a
12	chr8:10555466-10555516	GM06990	blood:	n/a
13	chr8:10558000-10558050	SKMC	muscle:	n/a
14	chr8:10558000-10558050	Jurkat	blood:	n/a
15	chr8:10555466-10555516	HMEC	breast:	n/a
16	chr8:10553728-10553778	HCF	heart:	n/a
17	chr8:10555382-10555432	HRCEpiC	kidney:	n/a
18	chr8:10558000-10558050	MCF-7	breast:	n/a
19	chr8:10553728-10553778	U87	brain:	n/a
20	chr8:10555466-10555516	HRE	kidney:	n/a
21	chr8:10553728-10553778	AoSMC	blood vessel:	n/a
22	chr8:10555382-10555432	HIPEpiC	eye:	n/a
23	chr8:10555382-10555432	K562	blood:	n/a
24	chr8:10555466-10555516	MCF10A-Er-Src	breast:	n/a
25	chr8:10555382-10555432	Hepatocyte	liver:	n/a
26	chr8:10555466-10555516	GM12878	blood:	n/a
27	chr8:10558000-10558050	SK-N-MC	brain:	n/a
28	chr8:10553728-10553778	BE2_C	brain:	n/a
29	chr8:10555466-10555516	CMK	blood:	n/a
30	chr8:10555466-10555516	MCF-7	breast:	n/a
31	chr8:10553728-10553778	H1-hESC	embryonic stem cell:	embryo
32	chr8:10555382-10555432	GM12891	blood:	n/a
33	chr8:10553728-10553778	SK-N-SH_RA	brain:	n/a
34	chr8:10553728-10553778	HepG2	liver:	n/a
35	chr8:10558000-10558050	IMR90	lung:	fetal
36	chr8:10555466-10555516	LNCaP	prostate:	n/a
37	chr8:10558000-10558050	GM12892	blood:	n/a
38	chr8:10555382-10555432	HUVEC	blood vessel:	n/a
39	chr8:10555382-10555432	NHBE	bronchial:	n/a
40	chr8:10555466-10555516	NHBE	bronchial:	n/a
41	chr8:10555382-10555432	Hela-S3	cervix:	n/a
42	chr8:10555466-10555516	BE2_C	brain:	n/a
43	chr8:10555382-10555432	HNPCEpiC	eye:	n/a
44	chr8:10553728-10553778	RPTEC	kidney:	n/a
45	chr8:10558000-10558050	GM12878	blood:	n/a
46	chr8:10555466-10555516	AG10803	skin:	n/a
47	chr8:10555466-10555516	NT2-D1	testis:	n/a
48	chr8:10553728-10553778	GM06990	blood:	n/a
49	chr8:10553728-10553778	GM19239	blood:	n/a
50	chr8:10555466-10555516	HCPEpiC	choroid plexus:	n/a

(count:21 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr8:10564366..10566017-chr8:10568811..10571288,2	K562	blood:
2	chr8:10553523..10556097-chr8:10561265..10564003,2	K562	blood:
3	chr8:10556097..10559916-chr8:10561605..10564138,3	K562	blood:
4	chr8:10553813..10555777-chr8:10556607..10558383,2	K562	blood:
5	chr8:10535340..10537589-chr8:10540581..10542267,2	K562	blood:
6	chr8:10539212..10541927-chr8:10542466..10544181,2	K562	blood:
7	chr8:10563640..10566502-chr8:10586406..10589328,2	K562	blood:
8	chr8:10556318..10558383-chr8:10558421..10560305,2	MCF-7	breast:
9	chr8:10556318..10558383-chr8:10558421..10560305,2	MCF-7	breast:
10	chr8:10561128..10563766-chr8:10580957..10583552,2	K562	blood:
11	chr8:10539212..10540819-chr8:10542466..10545338,2	K562	blood:
12	chr8:10534702..10537389-chr8:10561883..10564793,2	K562	blood:
13	chr8:10537022..10539383-chr8:10695484..10697412,2	K562	blood:
14	chr8:10549207..10552160-chr8:10577938..10579847,2	K562	blood:
15	chr8:10556097..10559916-chr8:10561605..10564138,3	K562	blood:
16	chr8:10553813..10555777-chr8:10556607..10558383,2	K562	blood:
17	chr19:16180029..16180673-chr8:10548540..10549342,2	Hela-S3	cervix:
18	chr8:10553523..10556097-chr8:10561265..10564003,2	K562	blood:
19	chr8:10555796..10558370-chr8:10558494..10560524,2	K562	blood:
20	chr8:10555796..10558370-chr8:10558494..10560524,2	K562	blood:
21	chr8:10561879..10564186-chr8:10576793..10578956,2	K562	blood:

No data

Variant related genes	Relation type
RNA5SP252	TF binding region
RNA5SP252	CpG island
ENSG00000248896	chromatin interactions
ENSG00000258724	chromatin interactions
ENSG00000183638	chromatin interactions
ENSG00000171056	chromatin interactions
ENSG00000212433	chromatin interactions
ENSG00000254093	chromatin interactions

Extended variants
information (count: 1608 )
Associated
traits (count: 138 )

Variant overlapped rSNPs/rCNVs (count:1608 , 50 per page) page: 1 2 3 4 5 6 7 ... 33

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7838749	chr8:10537940-10537941	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs368302589	chr8:10537951-10537952	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs539915832	chr8:10537983-10537984	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs138976013	chr8:10537994-10537995	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs556895002	chr8:10538011-10538012	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs576862797	chr8:10538014-10538015	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs545813938	chr8:10538054-10538055	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs577064635	chr8:10538056-10538057	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs531218592	chr8:10538084-10538085	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs371857573	chr8:10538131-10538132	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs551173750	chr8:10538135-10538136	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs141532107	chr8:10538193-10538194	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs530218408	chr8:10538200-10538201	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs546728672	chr8:10538207-10538208	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs79216783	chr8:10538219-10538220	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs538686521	chr8:10538232-10538233	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs552137070	chr8:10538242-10538243	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs181494268	chr8:10538246-10538247	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs537722633	chr8:10538272-10538273	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs11773917	chr8:10538280-10538281	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs185523773	chr8:10538285-10538286	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs369026134	chr8:10538286-10538287	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs553958653	chr8:10538297-10538298	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs112825569	chr8:10538308-10538309	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs112735309	chr8:10538309-10538310	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs4531009	chr8:10538314-10538315	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs556165473	chr8:10538330-10538331	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs189985362	chr8:10538336-10538337	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs79055385	chr8:10538340-10538341	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs561533809	chr8:10538352-10538353	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs180863925	chr8:10538373-10538374	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs185913723	chr8:10538374-10538375	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs560247526	chr8:10538383-10538384	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs4540376	chr8:10538395-10538396	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs4311629	chr8:10538420-10538421	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs190741518	chr8:10538422-10538423	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs531645259	chr8:10538429-10538430	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs113766097	chr8:10538465-10538466	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs548139072	chr8:10538480-10538481	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs568343245	chr8:10538492-10538493	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs533789217	chr8:10538509-10538510	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs553995745	chr8:10538510-10538511	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs570593066	chr8:10538605-10538606	Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs539502669	chr8:10538641-10538642	Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs556202399	chr8:10538661-10538662	Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs573025910	chr8:10538674-10538675	Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs541804543	chr8:10538733-10538734	Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs555002276	chr8:10538753-10538754	Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs575060128	chr8:10538763-10538764	Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs138331787	chr8:10538815-10538816	Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:138)

Disease	PMID	Source
Crohn''s disease	19220326	CNVD
Psoriasis	19220326	CNVD
Prostate cancer	21965145	CNVD
Prostate cancer	18515986	CNVD
Chronic obstructive pulmonary disease	20378733	CNVD
Autism	18414403	CNVD
Cancer	21183584	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Breast cancer	17603634	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Ovarian cancer	20844748	CNVD
Cervical cancer	17311676	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Schizophrenia	20877625	CNVD
Disorders of sex development	21048976	CNVD
Colorectal cancer	16272173	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Breast cancer	17001317	CNVD
Thyroid cancer	19087340	CNVD
Multiple myeloma	16616336	CNVD
Hepatocellular carcinoma	22174799	CNVD
Heart disease	21282601	CNVD
Prostate cancer	16573809	CNVD
T-cell lymphomas	19863542	CNVD
Ovarian cancer	22174824	CNVD
Colorectal cancer	21297112	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Salivary gland tumor	18059337	CNVD
Breast cancer	17133270	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Breast cancer	17393978	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Breast cancer	20837533	CNVD
Squamous cell cancer	21044232	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	22429812	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Colorectal cancer	20709793	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Basal cell lymphoma	21115979	CNVD
Breast cancer	21264507	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Prostate cancer	21088497	CNVD
Breast cancer	20940404	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Gastric cancer	17167181	CNVD
Prostate cancer	16705090	CNVD
8p-syndrome	17576883	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	16968546	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Prostate cancer	17245344	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Cancer	16751803	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Autism	19415332	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Esophageal cancer	21851588	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21245420	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Breast cancer	21785460	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21509527	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Acute myeloid leukemia	21251322	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
lymphocytic leukemia	21291569	CNVD
Liver carcinoma	19366792	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Congenital diaphragmatic hernia	21064195	CNVD
Autism	22495311	CNVD
Myelofibrosis	22110671	CNVD
Intellectual disability	22045946	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Breast cancer	16608533	CNVD
Seminomas	18059402	CNVD
Lung cancer	18438408	CNVD
Lung squamous cell carcinoma	22363434	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Breast cancer	21990379	CNVD
Psoriasis	20403174	CNVD
Psoriasis	20663923	CNVD
Crohn''s disease	16909382	CNVD
Cancer	21129771	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Crohn''s disease	20877625	CNVD
Inflammatory disorder	20877625	CNVD
Cardiac defect	21933911	CNVD
Psoriasis	18059266	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Psoriasis	20877625	CNVD
Mental retardation	17847001	CNVD
Prostate cancer	17217626	CNVD
Schizophrenia	21399695	CNVD
Colorectal cancer	21128281	CNVD
Colorectal cancer	19455253	CNVD
Psoriasis	18848619	CNVD
Squamous cell cancer	19047905	CNVD
Colorectal cancer	17229543	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Myxofibrosarcoma	16751306	CNVD
Immune disease	21572526	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Kallmann Syndrome 2	22470819	CNVD
Developmental disorder	20461109	CNVD
abnormal development	18461090	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Glioblastoma multiforme	21138945	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21364760	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Gastric cancer	21811585	CNVD
Colorectal cancer	16774939	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:158 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:10533200-10538200	Weak transcription	Pancreas	Pancrea
2	chr8:10536000-10538000	Enhancers	A549	lung
3	chr8:10536200-10540600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
4	chr8:10536800-10539000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
5	chr8:10536800-10539200	Enhancers	NHEK	skin
6	chr8:10536800-10541800	Enhancers	Spleen	Spleen
7	chr8:10537000-10539000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
8	chr8:10537000-10539200	Flanking Active TSS	Hela-S3	cervix
9	chr8:10537000-10542000	Enhancers	Esophagus	oesophagus
10	chr8:10537400-10538000	Weak transcription	Lung	lung
11	chr8:10537600-10538600	Weak transcription	Fetal Muscle Leg	muscle
12	chr8:10537600-10539400	Enhancers	HUVEC	blood vessel
13	chr8:10537600-10539600	Enhancers	Gastric	stomach
14	chr8:10537800-10538200	Bivalent Enhancer	Duodenum Mucosa	Duodenum
15	chr8:10537800-10539000	Enhancers	Liver	Liver
16	chr8:10537800-10539200	Enhancers	Brain Germinal Matrix	brain
17	chr8:10538000-10539000	Enhancers	NH-A	brain
18	chr8:10538000-10539200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
19	chr8:10538000-10539200	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
20	chr8:10538000-10539200	Bivalent Enhancer	Stomach Mucosa	stomach
21	chr8:10538000-10539200	Flanking Active TSS	A549	lung
22	chr8:10538000-10539400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
23	chr8:10538000-10539400	Enhancers	HMEC	breast
24	chr8:10538000-10539600	Enhancers	Breast Myoepithelial Primary Cells	Breast
25	chr8:10538000-10539800	Enhancers	Lung	lung
26	chr8:10538200-10538800	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
27	chr8:10538200-10539200	Enhancers	Duodenum Mucosa	Duodenum
28	chr8:10538200-10540200	Enhancers	Pancreas	Pancrea
29	chr8:10538400-10538600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
30	chr8:10538400-10538800	Bivalent Enhancer	Stomach Smooth Muscle	stomach
31	chr8:10538600-10538800	Enhancers	Fetal Muscle Leg	muscle
32	chr8:10538600-10539000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
33	chr8:10539000-10539400	Bivalent Enhancer	Right Ventricle	heart
34	chr8:10539000-10542800	Weak transcription	Liver	Liver
35	chr8:10539200-10539400	Enhancers	Stomach Mucosa	stomach
36	chr8:10539200-10539600	Enhancers	A549	lung
37	chr8:10539200-10540200	Enhancers	Hela-S3	cervix
38	chr8:10539400-10540400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
39	chr8:10539400-10541400	Weak transcription	HUVEC	blood vessel
40	chr8:10540200-10541400	Weak transcription	Pancreas	Pancrea
41	chr8:10540400-10541000	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
42	chr8:10540800-10541600	Enhancers	Lung	lung
43	chr8:10541000-10547400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
44	chr8:10541400-10541600	Enhancers	Pancreas	Pancrea
45	chr8:10541400-10541800	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
46	chr8:10541400-10542200	Enhancers	HUVEC	blood vessel
47	chr8:10541800-10546600	Weak transcription	Spleen	Spleen
48	chr8:10542000-10547400	Weak transcription	Esophagus	oesophagus
49	chr8:10542800-10543200	Enhancers	A549	lung
50	chr8:10542800-10543600	Enhancers	Liver	Liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links